Authors

Latest Article

What You Need to Know About Amantadine for Parkinson Disease

This guide includes everything you need to know about amantadine (Osmolex ER, Osmotica Pharmaceuticals) for the treatment of Parkinson disease and drug-induced extrapyramidal reactions in adults.

Eveline Honig, MD, MPH

Peter LeWitt, MD, M.Med.Sc

Will Pass, DVM

Latest Article

Sigma-1 Agonists Offer Combination Approach to Dementia Symptoms

6 years ago

Research from the past decade suggests that sigma-1 receptors and their encoding gene, SIGMAR1, together act as a therapeutic target for patients with dementia.

Krithika Subramanian, PhD

Latest Article

Targeting the NF-kB Pathway in Duchenne Muscular Dystrophy

6 years ago

An in-depth analysis of the genetics of DMD and disease modifiers such as the NF-kB pathway in patients with Duchenne muscular dystrophy.

Jeffrey Kaplan, MD

Akshay Desai, MD, MPH

Erin M. Burns, PhD, MSPH

Latest Article

Targeting the Neonatal Fc Receptor in Myasthenia Gravis

6 years ago

Understanding the pathophysiology of myasthenia gravis is still being determined to this day, but the neonatal Fc receptor is emerging as a potential treatment.

Mary Curry, ND

Latest Article

Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers

5 years ago

Advocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.

Yasir Al-Khalili, MD

Latest Article

The Challenges of Stroke Care in Rural America

5 years ago

Stroke care, including acute treatment and prevention, faces unique challenges in rural areas where disease awareness is lacking and access to high-level care in scarce.

Whitney Palmer

Latest Article

Neurologic Complications of COVID-19 Reported

5 years ago

The first presumptive case of acute necrotizing encephalopathy in a patient with confirmed COVID-19 has been published in the journal Radiology.

Hannah Kent Ritchie, PhD

Latest Article

COMT Inhibitors Assist in Control of Parkinson Disease Motor Symptoms

7 years ago

More recently, investigators have discovered that catechol-O-methyltransferase inhibitors can prolong the effects of levodopa, thereby limiting the off-time phenomenon.

Krista Rossi

Latest Article

California Startup Exploring Novel ALS Discovery Platform

7 years ago

A grant from the National Institute of Neurological Disorders and Stroke, which allows for concurrent phase I and II trial design review, will speed up the development of novel treatments for patients with ALS and FTD.

Victor Ferastraoaru, MD

Latest Article

EEG Abnormalities in Acutely Ill Patients With COVID-19

5 years ago

Preliminary findings from a retrospective sample series in the Bronx, New York.

Alexis Boro, MD

Latest Article

EEG Abnormalities in Acutely Ill Patients With COVID-19

5 years ago

Preliminary findings from a retrospective sample series in the Bronx, New York.

Jill M. Giordano Farmer, DO, MPH, Rajesh Pahwa, MD, Daniel E. Kremens, MD, JD, Peter LeWitt, MD, M.Med.Sc, Stuart Isaacson, MD

Nicola Davies, PhD

Latest Article

How Big Data Can Drive Advancements in MS Research

5 years ago

Big data is on the precipice of revolutionizing multiple sclerosis knowledge and treatment.

Danielle B. Cross, MD, MS

Latest Article

Everyone Is Working Hard: Why Shift Work Shouldn't Be Celebrated

6 years ago

Danielle B. Cross, MD, MS, a neurology resident in training, shares her thoughts on why glorifying exhaustion is unhealthy.

Jeffrey M. Kaplan, MD

Elizabeth A. Kichula, MD, PhD

Latest Article

Highly Effective Gene Therapies for SMA: Where Do We Go From Here?

3 years ago

Neuromuscular medicine has entered an era of genetic therapy, opening the doors to questions about possible combination approaches and earlier initiation of treatment.

Cecilia Pessoa Gingerich

Latest Article

FDA Grants Alzheimer Biomarker Test Breakthrough Status

7 years ago

The FDA has granted a Breakthrough Device Designation to the Elecsys beta-Amyloid (1-42) and Elecsys Phospho-Tau (181P) cerebrospinal fluid assays, which can be used in the diagnosis of Alzheimer disease.

Kevin McGehrin, MD

Latest Article

Challenges and Opportunities Bringing Lecanemab to Neurology Community Clinics 

a year ago

A group of experts from The Neuron Clinic shared their experience developing a novel inclusive clinical program to treat patients with early Alzheimer disease using lecanemab.

Luke Halpern

Latest Article

Evolving Approaches to the Diagnosis and Management of Paraneoplastic Neurologic Syndromes: Ditte Primdahl, MD; Shailee Samir Shah, MD

4 months ago

A duo of experts from Feinberg School of Medicine discussed the growing role of clinical algorithms, risk stratification, and treatment considerations in managing paraneoplastic neurologic syndromes alongside cancer therapies. [WATCH TIME: 4 minutes]

Ellen L. Air, MD, PhD

Latest Article

A Team Approach to Asleep Deep Brain Stimulation

5 years ago

Henry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care has helped them become a leading treatment center for Parkinson disease and related movement disorders.

Neal K. Shah

Latest Article

Taking on America’s Health Insurance Bureaucracy With AI

7 months ago

Neal K. Shah talked about an artificial intelligence innovation that can be used to fight denied health insurance claims, thus improving revenue cycle management for physicians' practices and the patient experience.

Melissa Rayhill, MD, FAHS, FAAN

Latest Article

Implementing Headache Training in Residency

2 years ago

Despite a tremendous burden regarding migraine-related disability and expenditure, headache disorders remain underdiagnosed and undertreated, and only a small percentage of patients report satisfaction with the treatment received.

Galina Nesterova, MD

Latest Article

PPD/TFS Fostering Global Awareness in Rare Disorders

2 years ago

Rare Disease Day raises awareness for rare disorders, highlighting challenges, improving detection, and fostering collaboration for treatment advancements.

Sarah Yang, MD

Latest Article

An Overview of Therapeutic Options for Amyotrophic Lateral Sclerosis

3 years ago

With an anticipated life expectancy of 3 years from the time of symptom onset, an effective treatment strategy is essential in ALS—and recent therapeutic progress has built a foundation of hope for the community.

Yolanda A. Yu, DO

Latest Article